Federated Hermes
IMGN

Federated Hermes’s Immunogen Inc IMGN Stock Holding History

Federated Hermes’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-609
Closed -$9.66K – 2247
2023
Q3 		$9.66K Sell
609
-180
-23% -$2.99K ﹤0.01% 1830
2023
Q2 		$14.9K Buy
789
+778
+7,073% +$9.19K ﹤0.01% 1809
2023
Q1 		$42 Buy
11
+2
+22% +$9 ﹤0.01% 2108
2022
Q4 		$45 Buy
9
+4
+80% +$22 ﹤0.01% 2133
2022
Q3 		$1K Sell
5
-35
-88% -$185 ﹤0.01% 2105
2022
Q2 		$2K Buy
40
+38
+1,900% +$165 ﹤0.01% 2008
2022
Q1 		$1K Buy
2
+1
+100% +$6 ﹤0.01% 2138
2021
Q4 		$1K Buy
+1
New +$6 ﹤0.01% 2175
2021
Q3 		– Sell
-154,043
Closed -$1.01M – 2345
2021
Q2 		$1.01M Sell
154,043
-384,712
-71% -$2.68M ﹤0.01% 1316
2021
Q1 		$4.36M Buy
538,755
+538,233
+103,110% +$4.39M 0.01% 888
2020
Q4 		$3K Sell
522
-10,724
-95% -$62.5K ﹤0.01% 2107
2020
Q3 		$40K Sell
11,246
-346
-3% -$1.4K ﹤0.01% 1814
2020
Q2 		$54K Sell
11,592
-234,409
-95% -$997K ﹤0.01% 1772
2020
Q1 		$839K Buy
246,001
+117,295
+91% +$513K ﹤0.01% 1213
2019
Q4 		$657K Buy
128,706
+128,148
+22,966% +$435K ﹤0.01% 1387
2019
Q3 		$2K Buy
+558
New +$1.48K ﹤0.01% 2049
2018
Q3 		– Sell
-53,455
Closed -$520K – 2348
2018
Q2 		$520K Buy
53,455
+32,812
+159% +$346K ﹤0.01% 1410
2018
Q1 		$217K Buy
20,643
+3,430
+20% +$33.9K ﹤0.01% 1509
2017
Q4 		$110K Sell
17,213
-55,977
-76% -$345K ﹤0.01% 1585
2017
Q3 		$560K Sell
73,190
-64,842
-47% -$431K ﹤0.01% 1335
2017
Q2 		$981K Buy
138,032
+112,525
+441% +$515K ﹤0.01% 1215
2017
Q1 		$99K Sell
25,507
-82,597
-76% -$241K ﹤0.01% 1566
2016
Q4 		$221K Buy
108,104
+44,353
+70% +$89K ﹤0.01% 1485
2016
Q3 		$171K Buy
63,751
+63,639
+56,821% +$185K ﹤0.01% 1496
2016
Q2 		$1K Buy
+112
New +$702 ﹤0.01% 2059
2014
Q4 		– Sell
-4,831
Closed -$51K – 2067
2014
Q3 		$51K Buy
+4,831
New +$54.6K ﹤0.01% 1653

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Federated Hermes's IMGN Position: Q4 2023 in Review

Federated Hermes sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 609 shares — an estimated $9.66K sold.

Federated Hermes first reported a position in IMGN in Q3 2014 and held it in 26 quarters. The position peaked at $4.36M in Q1 2021. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Federated Hermes reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Federated Hermes sold 609 Immunogen Inc shares in Q4 2023, an estimated $9.66K.
  • Federated Hermes first reported a position in Immunogen Inc in Q3 2014 and held it in 26 quarters.
  • Federated Hermes's Immunogen Inc position peaked at $4.36M in Q1 2021.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.